Financials of Marksans Pharma Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Marksans Pharma Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +486500531586560591642682708620720754856
Expenses +376398417453450462495543582520576594661
Operating Profit110102114133110128147139127100144161195
OPM %23%20%21%23%20%22%23%20%18%16%20%21%23%
Other Income +11101951715-028156222035
Interest2223533336666
Depreciation14141822212020212323272424
Profit before tax1049711411310012012514311677133151200
Tax %21%27%26%26%23%26%22%27%22%24%26%25%25%
Net Profit +83708483788998105915899114149
EPS in Rs1.811.521.841.841.731.962.132.312.001.292.172.503.27

Financials of Marksans Pharma Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +7978937679131,0001,1341,3761,4911,8522,1772,6232,951
Expenses +6127577228348689421,0371,2321,5131,7192,0942,350
Operating Profit1851364578132192340259340459529601
OPM %23%15%6%9%13%17%25%17%18%21%20%20%
Other Income +39785074259507083
Interest1610710109889111224
Depreciation162830272327364552748399
Profit before tax1561071550104157302248338424504561
Tax %28%23%24%28%23%23%21%25%21%26%24%25%
Net Profit +11283113680121239187265315383420
EPS in Rs2.671.920.220.801.872.955.764.515.886.928.409.22
Dividend Payout %4%21%23%6%3%3%4%6%9%9%10%0%

Financials of Marksans Pharma Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital414141414141414145454545
Reserves3264013924305025958461,1611,7002,0202,4222,978
Borrowings +1011001101181003034111123244322343
Other Liabilities +207180209142160236307323322372451494
Total Liabilities6767227527318029021,2281,6362,1902,6813,2403,861
Fixed Assets +1662702672792703033094284867769821,088
CWIP0000001231092715
Investments0000000012710
Other Assets +5104524844515335999071,2051,6941,8692,2302,758
Total Assets6767227527318029021,2281,6362,1902,6813,2403,861

Financials of Marksans Pharma Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +1553114502723317999237230207458
Cash from Investing Activity +-33-123-21-39-13-60-45-84-259-141-49-248
Cash from Financing Activity +17-58-33-21-114-1580198-69-65-71
Net Cash Flow138-150-1015-760118941762193139
Free Cash Flow118-101-141114174133531842235329
CFO/OP108%43%31%73%41%134%67%66%88%77%63%100%

Financials of Marksans Pharma Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days8489118716478729782767580
Inventory Days107120151152215155248216192217270278
Days Payable888512954787110310291949896
Cash Conversion Cycle103124140169202163217211183199247261
Working Capital Days175977709787104121122129142149
ROCE %44%23%4%10%18%25%38%23%22%21%20%19%